Your GP may refer you to gynaecology or endocrinology services if menstrual disturbances persist despite appropriate management, or if there are features suggesting underlying hormonal disorders beyond the effects of weight change

Preclinical validation includes rabbit HCC models demonstrating significant histological advantages of IRE over RE and untreated controls: IRE zones exhibited 51-60% fewer tumor cells, 66-67% reduced microvasculature, and 185-228% increased cell death ( in vitro with distinct ultrastructural changes observed via TEM, achieves complete ablation in rabbit VX2 liver tumors under contrast-enhanced ultrasound guidance ( + extracellular vesicle release, causing CD8 + T-cell dysfunctionan effect reversed by PD-L1 blockade to significantly suppress tumor growth and improve survival ( + T-cell and dendritic cell infiltration in peri-ablational zones ( + T cell necroptosis yet attenuating pro-tumor inflammatory populations ( + mononuclear phagocyte differentiation and memory CD8 + T-cell formation in human trials ( 3.3 Prostate cancer Emerging clinical evidence establishes IRE as a safe and effective modality for prostate cancer treatment, with recent studies highlighting its capacity to potentiate checkpoint immunotherapy

APC held a call with reporters earlier this month, saying that the FDAs initial decision had caught compounding pharmacies off guard and left patients flat-footed. Lilly had first indicated in August that the tirzepatide shortage would be resolved soon, two months before the official FDA decision
As research continues to explore and validate these claims, it is clear that semaglutide could represent a significant step forward in our quest to not just treat disease, but to enhance and extend life itself
Synapse 22, 3545
The SURMOUNT-5 trial data you may have seen comparing tirzepatide and semaglutide head-to-head showed tirzepatide outperforming semaglutide at approximately 20.2% vs